{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:47:19Z","timestamp":1789192039153,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T00:00:00Z","timestamp":1483574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T00:00:00Z","timestamp":1483574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary sclerosing cholangitis (PSC) is a cholestatic liver disease of unknown etiopathogenesis characterized by fibrous cholangiopathy of large and small bile ducts. Systemic administration of a murine TNF-related apoptosis-inducing ligand (TRAIL) receptor agonist induces a sclerosing cholangitis injury in C57BL\/6 mice, suggesting endogenous TRAIL may contribute to sclerosing cholangitis syndromes. Cellular inhibitor of apoptosis proteins (cIAP-1 and cIAP-2) are negative regulators of inflammation and TRAIL receptor signaling. We hypothesized that if endogenous TRAIL promotes sclerosing cholangitis, then cIAP depletion should also induce this biliary tract injury. Herein, we show that cIAP protein levels are reduced in the interlobular bile ducts of human PSC livers. Downregulation of cIAPs in normal human cholangiocytes <jats:italic>in vitro<\/jats:italic> by use of a SMAC mimetic (SM) induces moderate, ripoptosome-mediated apoptosis and RIP1-independent upregulation of proinflammatory cytokines and chemokines. Cytokine and chemokine expression was mediated by the non-canonical activation of NF-<jats:italic>\u03ba<\/jats:italic>B. To investigate whether downregulation of cIAPs is linked to generation of a PSC-like phenotype, an SM was directly instilled into the mouse biliary tree. Twelve hours after biliary instillation, TUNEL-positive cholangiocytes were identified; 5 days later, PSC-like changes were observed in the SM-treated mice, including a fibrous cholangiopathy of the interlobular bile ducts, portal inflammation, significant elevation of serum markers of cholestasis and cholangiographic evidence of intrahepatic biliary tract injury. In contrast, TRAIL and TRAIL-receptor deficient mice showed no sign of cholangiopathy following SM intrabiliary injection. We conclude that <jats:italic>in vivo<\/jats:italic> antagonism of cIAPs in mouse biliary epithelial cells is sufficient to trigger cholangiocytes apoptosis and a proinflammatory response resulting in a fibrous cholangiopathy resembling human sclerosing cholangitis. Therefore, downregulation of cIAPs in PSC cholangiocytes may contribute to the development of the disease. Our results also indicate that inhibition of TRAIL signaling pathways may be beneficial in the treatment of PSC.<\/jats:p>","DOI":"10.1038\/cddis.2016.459","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T13:44:59Z","timestamp":1483623899000},"page":"e2535-e2535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Maria Eugenia","family":"Guicciardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F","family":"Bronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Hirsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J","family":"Gores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"key":"BFcddis2016459_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","volume":"145","author":"JE Eaton","year":"2013","unstructured":"Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD . Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 2013; 145: 521\u2013536.","journal-title":"Gastroenterology"},{"key":"BFcddis2016459_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/lt.21679","volume":"15","author":"E Alabraba","year":"2009","unstructured":"Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 2009; 15: 330\u2013340.","journal-title":"Liver Transpl"},{"key":"BFcddis2016459_CR3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1053\/gast.2002.35948","volume":"123","author":"P Fickert","year":"2002","unstructured":"Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002; 123: 1238\u20131251.","journal-title":"Gastroenterology"},{"key":"BFcddis2016459_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.clinre.2011.04.014","volume":"35","author":"MJ Pollheimer","year":"2011","unstructured":"Pollheimer MJ, Trauner M, Fickert P . Will we ever model PSC? \u2013 \u2018it's hard to be a PSC model!\u2019. Clin Res Hepatol Gastroenterol 2011; 35: 792\u2013804.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"BFcddis2016459_CR5","doi-asserted-by":"publisher","first-page":"10895","DOI":"10.1073\/pnas.0802702105","volume":"105","author":"K Takeda","year":"2008","unstructured":"Takeda K, Kojima Y, Ikejima K, Harada K, Yamashina S, Okumura K et al. Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci USA 2008; 105: 10895\u201310900.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016459_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1126\/science.1098231","volume":"305","author":"L Li","year":"2004","unstructured":"Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, Harran PG . A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science 2004; 305: 1471\u20131474.","journal-title":"Science"},{"key":"BFcddis2016459_CR7","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1158\/1078-0432.CCR-13-2376","volume":"20","author":"S Fulda","year":"2014","unstructured":"Fulda S . Molecular pathways: targeting death receptors and smac mimetics. Clin Cancer Res 2014; 20: 3915\u20133920.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2016459_CR8","doi-asserted-by":"publisher","first-page":"24295","DOI":"10.1074\/jbc.C800128200","volume":"283","author":"E Varfolomeev","year":"2008","unstructured":"Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 2008; 283: 24295\u201324299.","journal-title":"J Biol Chem"},{"key":"BFcddis2016459_CR9","doi-asserted-by":"publisher","first-page":"ra22","DOI":"10.1126\/scisignal.2001878","volume":"5","author":"E Varfolomeev","year":"2012","unstructured":"Varfolomeev E, Goncharov T, Maecker H, Zobel K, Komuves LG, Deshayes K et al. Cellular inhibitors of apoptosis are global regulators of NF-kappaB and MAPK activation by members of the TNF family of receptors. Sci Signal 2012; 5: ra22.","journal-title":"Sci Signal"},{"key":"BFcddis2016459_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden MS, Ghosh S . Shared principles in NF-kappaB signaling. Cell 2008; 132: 344\u2013362.","journal-title":"Cell"},{"key":"BFcddis2016459_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"ND Perkins","year":"2007","unstructured":"Perkins ND . Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007; 8: 49\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis2016459_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cell.2007.10.037","volume":"131","author":"JE Vince","year":"2007","unstructured":"Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007; 131: 682\u2013693.","journal-title":"Cell"},{"key":"BFcddis2016459_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","volume":"131","author":"E Varfolomeev","year":"2007","unstructured":"Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007; 131: 669\u2013681.","journal-title":"Cell"},{"key":"BFcddis2016459_CR14","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/ni.1678","volume":"9","author":"S Vallabhapurapu","year":"2008","unstructured":"Vallabhapurapu S, Matsuzawa A, Zhang W, Tseng PH, Keats JJ, Wang H et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol 2008; 9: 1364\u20131370.","journal-title":"Nat Immunol"},{"key":"BFcddis2016459_CR15","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.4161\/cc.7.11.5959","volume":"7","author":"E Varfolomeev","year":"2008","unstructured":"Varfolomeev E, Vucic D . (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways. Cell Cycle 2008; 7: 1511\u20131521.","journal-title":"Cell Cycle"},{"key":"BFcddis2016459_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1097-2765(01)00187-3","volume":"7","author":"G Xiao","year":"2001","unstructured":"Xiao G, Harhaj EW, Sun SC . NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 2001; 7: 401\u2013409.","journal-title":"Mol Cell"},{"key":"BFcddis2016459_CR17","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/cr.2009.57","volume":"19","author":"W Tang","year":"2009","unstructured":"Tang W, Wang W, Zhang Y, Liu S, Liu Y, Zheng D . TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent manner. Cell Res 2009; 19: 758\u2013767.","journal-title":"Cell Res"},{"key":"BFcddis2016459_CR18","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/sj.cdd.4402027","volume":"13","author":"JE Vince","year":"2006","unstructured":"Vince JE, Silke J . TWEAK shall inherit the earth. Cell Death Differ 2006; 13: 1842\u20131844.","journal-title":"Cell Death Differ"},{"key":"BFcddis2016459_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1083\/jcb.200801010","volume":"182","author":"JE Vince","year":"2008","unstructured":"Vince JE, Chau D, Callus B, Wong WW, Hawkins CJ, Schneider P et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol 2008; 182: 171\u2013184.","journal-title":"J Cell Biol"},{"key":"BFcddis2016459_CR20","doi-asserted-by":"publisher","first-page":"339ra369","DOI":"10.1126\/scitranslmed.aad3099","volume":"8","author":"G Brumatti","year":"2016","unstructured":"Brumatti G, Ma C, Lalaoui N, Nguyen NY, Navarro M, Tanzer MC et al. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia. Sci Transl Med 2016; 8: 339ra369.","journal-title":"Sci Transl Med"},{"key":"BFcddis2016459_CR21","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1021\/jm500176w","volume":"57","author":"SM Condon","year":"2014","unstructured":"Condon SM, Mitsuuchi Y, Deng Y, LaPorte MG, Rippin SR, Haimowitz T et al. Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies. J Med Chem 2014; 57: 3666\u20133677.","journal-title":"J Med Chem"},{"key":"BFcddis2016459_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.molcel.2011.06.006","volume":"43","author":"T Tenev","year":"2011","unstructured":"Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011; 43: 432\u2013448.","journal-title":"Mol Cell"},{"key":"BFcddis2016459_CR23","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1074\/jbc.M112.422410","volume":"288","author":"CJ Kearney","year":"2013","unstructured":"Kearney CJ, Sheridan C, Cullen SP, Tynan GA, Logue SE, Afonina IS et al. Inhibitor of apoptosis proteins (IAPs) and their antagonists regulate spontaneous and tumor necrosis factor (TNF)-induced proinflammatory cytokine and chemokine production. J Biol Chem 2013; 288: 4878\u20134890.","journal-title":"J Biol Chem"},{"key":"BFcddis2016459_CR24","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/cdd.2011.10","volume":"18","author":"M Darding","year":"2011","unstructured":"Darding M, Feltham R, Tenev T, Bianchi K, Benetatos C, Silke J et al. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2. Cell Death Differ 2011; 18: 1376\u20131386.","journal-title":"Cell Death Differ"},{"key":"BFcddis2016459_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1084\/jem.189.8.1343","volume":"189","author":"TS Griffith","year":"1999","unstructured":"Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA . Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med 1999; 189: 1343\u20131354.","journal-title":"J Exp Med"},{"key":"BFcddis2016459_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1189\/jlb.0707452","volume":"83","author":"MP Simons","year":"2008","unstructured":"Simons MP, Leidal KG, Nauseef WM, Griffith TS . TNF-related apoptosis-inducing ligand (TRAIL) is expressed throughout myeloid development, resulting in a broad distribution among neutrophil granules. J Leukoc Biol 2008; 83: 621\u2013629.","journal-title":"J Leukoc Biol"},{"key":"BFcddis2016459_CR27","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X","volume":"28","author":"SM Mariani","year":"1998","unstructured":"Mariani SM, Krammer PH . Surface expression of TRAIL\/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol 1998; 28: 1492\u20131498.","journal-title":"Eur J Immunol"},{"key":"BFcddis2016459_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2567.2009.03058.x","volume":"127","author":"C Falschlehner","year":"2009","unstructured":"Falschlehner C, Schaefer U, Walczak H . Following TRAIL's path in the immune system. Immunology 2009; 127: 145\u2013154.","journal-title":"Immunology"},{"key":"BFcddis2016459_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molcel.2011.06.011","volume":"43","author":"M Feoktistova","year":"2011","unstructured":"Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M et al. cIAPs block Ripoptosome formation, a RIP1\/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011; 43: 449\u2013463.","journal-title":"Mol Cell"},{"key":"BFcddis2016459_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10495-010-0535-3","volume":"16","author":"TS Griffith","year":"2011","unstructured":"Griffith TS, Kucaba TA, O'Donnell MA, Burns J, Benetatos C, McKinlay MA et al. Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist. Apoptosis 2011; 16: 13\u201326.","journal-title":"Apoptosis"},{"key":"BFcddis2016459_CR31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","volume":"150","author":"P Hirsova","year":"2016","unstructured":"Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW et al. Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes. Gastroenterology 2016; 150: 956\u2013967.","journal-title":"Gastroenterology"},{"key":"BFcddis2016459_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcdb.2015.01.012","volume":"39","author":"SP Cullen","year":"2015","unstructured":"Cullen SP, Martin SJ . Fas and TRAIL 'death receptors' as initiators of inflammation: Implications for cancer. Semin Cell Dev Biol 2015; 39: 26\u201334.","journal-title":"Semin Cell Dev Biol"},{"key":"BFcddis2016459_CR33","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","volume":"177","author":"FO Martinez","year":"2006","unstructured":"Martinez FO, Gordon S, Locati M, Mantovani A . Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303\u20137311.","journal-title":"J Immunol"},{"key":"BFcddis2016459_CR34","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1091\/mbc.e15-04-0209","volume":"26","author":"J Gao","year":"2015","unstructured":"Gao J, Wang D, Liu D, Liu M, Ge Y, Jiang M et al. Tumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotype. Mol Biol Cell 2015; 26: 3178\u20133189.","journal-title":"Mol Biol Cell"},{"key":"BFcddis2016459_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","volume":"30","author":"TA Wynn","year":"2010","unstructured":"Wynn TA, Barron L . Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010; 30: 245\u2013257.","journal-title":"Semin Liver Dis"},{"key":"BFcddis2016459_CR36","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/hep.25691","volume":"56","author":"JM Banales","year":"2012","unstructured":"Banales JM, Saez E, Uriz M, Sarvide S, Urribarri AD, Splinter P et al. Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 2012; 56: 687\u2013697.","journal-title":"Hepatology"},{"key":"BFcddis2016459_CR37","first-page":"G1060","volume":"266","author":"SA Grubman","year":"1994","unstructured":"Grubman SA, Perrone RD, Lee DW, Murray SL, Rogers LC, Wolkoff LI et al. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am J Physiol 1994; 266: G1060\u2013G1070.","journal-title":"Am J Physiol"},{"key":"BFcddis2016459_CR38","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/labinvest.2012.121","volume":"92","author":"A Krishnan","year":"2012","unstructured":"Krishnan A, Li X, Kao WY, Viker K, Butters K, Masuoka H et al. Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis. Lab Invest 2012; 92: 1712\u20131725.","journal-title":"Lab Invest"},{"key":"BFcddis2016459_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1053\/j.gastro.2005.05.022","volume":"129","author":"ME Guicciardi","year":"2005","unstructured":"Guicciardi ME, Bronk SF, Werneburg NW, Yin XM, Gores GJ . Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factor alpha-induced hepatocyte apoptosis. Gastroenterology 2005; 129: 269\u2013284.","journal-title":"Gastroenterology"},{"key":"BFcddis2016459_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.yexcr.2010.10.005","volume":"317","author":"ME Guicciardi","year":"2011","unstructured":"Guicciardi ME, Mott JL, Bronk SF, Kurita S, Fingas CD, Gores GJ . Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Exp Cell Res 2011; 317: 107\u2013116.","journal-title":"Exp Cell Res"},{"key":"BFcddis2016459_CR41","first-page":"2770","volume":"59","author":"GS Wu","year":"1999","unstructured":"Wu GS, Burns TF, Zhan Y, Alnemri ES, El-Deiry WS . Molecular cloning and functional analysis of the mouse homologue of the KILLER\/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 1999; 59: 2770\u20132775.","journal-title":"Cancer Res"},{"key":"BFcddis2016459_CR42","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.4049\/jimmunol.168.3.1356","volume":"168","author":"E Cretney","year":"2002","unstructured":"Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ . Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 2002; 168: 1356\u20131361.","journal-title":"J Immunol"},{"key":"BFcddis2016459_CR43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0076-6879(06)10019-1","volume":"410","author":"G Lutfalla","year":"2006","unstructured":"Lutfalla G, Uze G . Performing quantitative reverse-transcribed polymerase chain reaction experiments. Methods Enzymol 2006; 410: 386\u2013400.","journal-title":"Methods Enzymol"},{"key":"BFcddis2016459_CR44","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nprot.2010.62","volume":"5","author":"M de Planell-Saguer","year":"2010","unstructured":"de Planell-Saguer M, Rodicio MC, Mourelatos Z . Rapid in situ codetection of noncoding RNAs and proteins in cells and formalin-fixed paraffin-embedded tissue sections without protease treatment. Nat Protoc 2010; 5: 1061\u20131073.","journal-title":"Nat Protoc"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2016459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016459","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T14:56:20Z","timestamp":1672671380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2016459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["BFcddis2016459"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.459","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"assertion":[{"value":"7 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}